Physician-validated entry
NuPulse’s clinical conviction, from the physicians who use the technology, is the signal institutional co-investors follow.
SPV-based syndication into cardiovascular companies already clinically validated and strategically positioned.
NuPulse’s clinical conviction, from the physicians who use the technology, is the signal institutional co-investors follow.
SPV-based syndication on disciplined, structured terms, with principal-protective features where they matter.
Deals already clinically validated and positioned toward clear strategic-buyer demand in cardiovascular medtech.
You invest alongside the clinical network, with preferred economics for the physicians who help create the value.
Participation is limited to accredited investors and is made only through definitive offering documents.
Contribute independent clinical insight to the evaluation of emerging cardiovascular technologies and, where appropriate, participate in separately structured investment opportunities.
Capital, candid physician assessment, and help positioning the company for the buyer most likely to acquire it.
Deal-by-deal SPV syndication into cardiovascular companies our physician network has already evaluated.
An external view of physician-validated cardiovascular companies as they become relevant to your portfolio.
We welcome conversations with founders, investors, physicians, and strategic partners in cardiovascular and electrophysiology medtech.
Email usMiami, Florida